Skip to main content
Heliyon logoLink to Heliyon
. 2024 Mar 13;10(7):e27508. doi: 10.1016/j.heliyon.2024.e27508

Molecular network mechanism in cerebral ischemia-reperfusion rats treated with human urine stem cells

Lang-Chun Zhang a,b,1, Na Li b,1, Ji-Lin Chen b, Jie Sun b, Min Xu b, Wen-Qiang Liu c, Zhong-Fu Zuo d, Lan-Lan Shi a, Ting-Hua Wang a,⁎, Xiang-Yin Luo a,⁎⁎
PMCID: PMC10979071  PMID: 38560254

Abstract

Objective

To explore the effect of human urine-derived stem cells (husc) in improving the neurological function of rats with cerebral ischemia-reperfusion (CIR), and report new molecular network by bioinformatics, combined with experiment validation.

Methods

After CIR model was established, and husc were transplanted into the lateral ventricle of rats,neurological severe score (NSS) andgene network analysis were performed. Firstly, we input the keywords “Cerebral reperfusion” and “human urine stem cells” into Genecard database and merged data with findings from PubMed so as to get their targets genes, and downloaded them to make Venny intersection plot. Then, Gene ontology (GO) analysis, kyoto encyclopedia of genes and genomes (KEGG) pathway analysis and protein-protein interaction (PPI) were performed to construct molecular network of core genes. Lastly, the expressional level of core genes was validated via quantitative real-time polymerase chain reaction (qRT-PCR), and localized by immunofluorescence.

Results

Compared with the Sham group, the neurological function of CIR rats was significantly improved after the injection of husc into the lateral ventricle; at 14 days, P = 0.028, which was statistically significant. There were 258 overlapping genes between CIR and husc, and integrated with 252 genes screened from PubMed and CNKI. GO enrichment analysis were mainly involved neutrophil degranulation, neutrophil activation in immune response and platelet positive regulation of degranulation, Hemostasis, blood coagulation, coagulation, etc. KEGG pathway analysis was mainly involved in complement and coagulation cascades, ECM-receptor. Hub genes screened by Cytoscape consist ofCD44, ACTB, FN1, ITGB1, PLG, CASP3, ALB, HSP90AA1, EGF, GAPDH. Lastly, qRT-PCR results showed statistic significance (P < 0.05) in ALB, CD44 and EGF before and after treatment, and EGF immunostaining was localized in neuron of cortex.

Conclusion

husc transplantation showed a positive effect in improving neural function of CIR rats, and underlying mechanism is involved in CD44, ALB, and EGF network.

Keywords: Cerebral ischemia reperfusion, Human urine stem cells, Bioinformatics

Graphical abstract

Image 1

1. Introduction

Cerebral ischemia (CI) has been well-known as one of the main causes of morbidity and mortality in the world, in which. Ischemic stroke will lead to neuronal damage while cerebral ischemia reperfusion (CIR) will aggravate the functional injury process [1], and effective therapy is missing, especially 4 h after CIR [2,3]. Not only can CIR lead to learning and memory impairment, neurological dysfunction and brain death, but also is associated with morbidity, mortality and disability, and the underlying mechanism is involving in inflammatory reaction (Hu, Y et al., 2019). Thrombolytic therapy is the standard treatment for ischemic stroke. However, reperfusion to restore cerebral blood flow in ischemic brain tissue eventually leads to irreversible brain damage, in which, a variety of complex molecular mechanisms, including excessive oxidative stress and inflammatory response, calcium overload and apoptotic cell death, are involved in the progression of ischemic injury.

Cell therapy is an effective strategy for the treatment of severe neurological diseases, especially ischemic stroke. It has been known that bone mesenchymal stromal cells (BMSC) transplantation is an effective strategy for the clinical treatment of ischemic stroke, and its benefits have been confirmed [4]. Definitely, BMSC can be used to repair or inhibit neurodegeneration by inhibiting cell death and secretion of a series of growth factors as well as anti-inflammatory cytokines in ischemic brain tissue [5]. In addition, a number of clinical studies have shown that (NSC) transplantation is an effective method to treat ischemic stroke through various mechanisms, such as protecting the blood-brain barrier (BBB), alleviating neuroinflammation in the brain, enhancing neurogenesis and angiogenesis, and achieving functional neurological recovery [6]. Additionally, NSC have been used in some experimental studies and preclinical trials, but invasive medical procedures to harvest NSC or MSC may present potential complications, serious ones may endanger the life of the donor. The ideal source of stem cells would be less harmful to the donor and easier to collect and expand in large numbers.

Human-derived urine (husc) can be collected easily without health risks throughout the patient's life cycle, they can even be collected daily [7]. These cells can effectively be induced as ectoderm and mesoderm and endoderm lineages [8]. The ectodermal neural lineage was obtained by adding basic fibroblast growth factor (bFGF) to neural induction medium, and about 40% of the induced cells expressed some neural markers and showed neurogenic extension and processes in vitro and in vivo [9]. Even though a few cells have a “rice-like” shape in urine, they can continuously multiply to more than 20 generations with a multiplication rate of more than 60. Currently, husc could be isolated from fresh urine and propagated in a simple, non-invasive and low-cost procedure [10,11], and also have differentiation potential and paracrine action [12]. However, no report to confirm the effect of husc in ischemic stroke model.

In this study, we used animal experiments to verify that transplantation effect of husc to improve the neural function in CIR rats, and using bioinformatics methods [13,14], to uncover the underlying molecular network mechanism.

2. Materials and methods

2.1. Culture and amplification of husc

A sterile urine sample approximately 300 ml was acquired from urine of health adult female, followed by a centrifugation at 1500 rpm for 10min, then the supernatant was gently poured out in the biosafety cabinet, and remaining 0.5 ml urine at the bottom was collected, washed again by urine cell cleaning. This was followed by an inoculation, at culture flask, and regular observation till and clone formation. Next, husc were cultured up to 3 passages, to amplify the number of urine stem cells, then identified by using immunofluorescence staining by specific marker.

During passage, the cells were re-suspended in a 15 ml centrifuge tube and centrifuged at 1500 rpm for 5min, then the supernatant was discarded and 1 ml urine stem cell special medium was added for re-suspension. Next, 80 μl urine special medium mixed with +10 μl 0.4% Trypan blue dye were added into 10 μl cell suspension for counting cell number in the cell counting apparatus, till the result display.

2.2. Animal model and husc administration

SD rats were purchased from Experimental Animal Center of Kunming Medical University, the production license number is SCXK (Yunnan) K2020-0004. To perform the experiment, all rats were divided into sham group(n = 7), CIR group (n = 10), and husc treated group(n = 6), with ethic number KMMU20220891. Before operation, the rats were fasted for 8–10 h, then anesthetized with 3% sodium pentobarbital. Subsequently, the common carotid artery, external carotid artery and internal carotid artery on the right side were separated and exposed again by the method of thread embolization. The thread plug was inserted into the internal carotid artery with depth 18 mm, and the thin wire at the distal end of CCA was tightly fastened. Then the wound was closed, and the tether was taken out 1 h later. To perform husc transplantatioin, a craniotomy was performed in the right lateral ventricle of the rats, coated 1.5 mm beside the sagittal line and 2 mm backward. Then,10 μl stem cells(1 × 105) were injected into lateral ventricle with stereolocator and microinjector. Lastly, the hole was sealed with bone wax after the injection [15].

2.3. Modified neurological severity scale (mNSS) assessment

The three groups of rats were evaluated for neurological severity on 1d,3d,5d,7d,10d and14d. There are 5 items in total: 1. Rat tail about 1 m away from the point (0–3 score); 2. Motor function observation (0∼3score); 3. Beam experiment (0–6 score); 4. Sensory function (0–2 score); 5. Reflex activity (0–4 score). Three people with blind will score at the same time, and the final results will be taken as the average score of three people for statistics.

2.4. TTC staining

Brain samples were cut into 2 mm thick sections. The sections were stained with 2,3,5-triphenyltetrazolium chloride TTC (2%) at 37 °C for 0.5 h and fixed with 4% paraformaldehyde at 4 °C overnight. Sections were photographed and the size of cerebral infarction was measured and analyzed with Image J.

2.5. Query CIR and hub gene targets

When open browser, we entered Genecards from Baidu. By using website (https://www. Genecards.org), we typed into “Cerebral reperfusion” and “Human urine stem” on Genecards database to search respective target gent and download the gene targets in Excel format. In Genecards database, the higher the Relevance score was, the more closely the target was, then they were preserved.

2.6. Venny diagram analysis of both CIR and husc

Venny intersection diagram was performed between CIR and husc, so as to obtain the intersection genes. Using Venny2.1 (https://bioinfogp.cnb.csic.es/tools/venny/),we entered respective target gene both CIR and husc, in List1 and List2, then acquired their cross genes, and changed their styles color, and downloaded images.

2.7. Integrate analysis with the genes from PubMed

Key words “Cerebral ischemia reperfusion”, and “Stem cell transplantation” were input so as to collect the latest findings that do not present in Genecards. Then we merged them into cross gene from Venny analysis.

2.8. GO and KEGG analysis

GO analysis, as an international standardized functional classification system of gene, provides dynamically updated control terms and strictly defined concepts to comprehensively describe the characteristics of genes and their products in any organism. GO enrichment analysis provided all of the GO terms, which were significantly enriched in target genes compared to the genomic background and filtered corresponding biofunctional target genes. In this study, all targets were mapped to the gene ontology database (http://www.geneontology). The number of genes per semester, and path-based analysis was used to characterize the biological function of the target, moreover, Pathway enrichment analysis was performed by using the application of KEGG pathways database (http://www.genome.jp/kegg/) to discover the important signal transduction pathways. To reach this aim, R software version 3.6.0 (http://www.r-project.org)was installed in the Java environment, and rSQLite, Cluster Profiler, and org are also required. Related, and Dose, enrich Plot, GGplot2, colorspace, stringi, pathView, are needed. Then all gene list was copied and pasted into the R software window for so and KEGG analysis. After enrichment analysis of GO and KEGG, histogram, bubble diagram and signal pathway diagram were plotted using dB, enrichment diagram and GGplot2, respectively.

2.9. PPI protein interaction

By using string Database (https://string-db.org/), 252 common genes were linked in string database and set biological species to “Homo” in the option of “organization”, then make protein interaction map, and export its high-definition interaction map (400PPI) and interaction relationship table. Meanwhile, hub genes were screened according to Degree value in Cytoscape, and 10 hub genes were noticed.

2.10. Quantificational real-time polymerase chain reaction (qRT-PCR) validation

To validate the core genes, the penumbra of brain tissues from each rat in respective group was harvested, then total RNA was extracted using Trizol, and cDNA was synthesized according to the reagent kit instructions. When the OD 260/OD 280 ratio of the extracted RNA samples ranged from 1.8 to 2.0, qRT-PCR was performed. The primer sequences are shown in Table 1. The reaction conditions were as follows: initial denaturation at 95 °C for 5 min, followed by 40 cycles of denaturation at 95 °C for 10s, and annealing and extension at 72 °C for 45 s. The relative expression of target genes was assessed using the 2−ΔΔCt method(Table 1).

Table 1.

Primers for Real-Time polymerase chain reaction.

Gene Sense primer Anti-sense primer
ACTB CCTCACTGTCCACCTTCCA GGGTGTAAAACGCAGCTCA
ALB CGTCAGAGGATGAAGTGCT TGGTGAGGTCTGTTGCC
CASP3 TGGACAACAACGAAACCTC ACACAAGCCCATTTCAGG
CD44 GTACATCAGTCACAGACCT CTGCTGACATCCTCATCTAT
FN1 ATTCTGTAGGCCGTTGGA TACTGCTGGATGCTGATGA
ITGB1 CGTGCGGAAGACAAGTG CTCACAATGGCACACAGG
PLG GCCCAACCTACCAATGTCT AGTTTTCTGGCGTCCTGTT
EGF GTAGTGGTGGCCCTTGG GCTGGGTGTGAGAGGTTC
GAPDH TCTTTGCTTGGGTGGGT TGGGTCTGGCATTGTTCT
HSP90AA1 TTTGGTGCCTGACTTGG TAAACTGGACTCGGGGAA

2.11. Immunofluorescent staining

The husc were harvested and performed immunofluorescence. After washed with 1× Phosphate-Buffered Saline, 0.1% Tween® 20 Detergent (PBST) (Batch no. P1003, SolarbioCat, China) solution was used for 5 × 5 min, and 5% sheep serum was used as a sealer, while 0.3% Triton solution (Batch no. EZ6789D142, Biofroxx) was designated as a cell permeabilizer to punch holes in the membrane. After standing at room temperature for 3 h, the cells were incubated with primary antibody (CD44, 1; 200, mouse, Boaishen; CD45, 1; 300, mouse, Boaoshen; CD90, 1:200, mouse) at 4 °C overnight, and they were continuously washed 5 times with PBST for 5 min each, followed by an incubated with fluorescent dye-labeled secondary antibody (488, anti-mouse, 1:200; cy3, anti-mouse, 1:200) at 37 °C for 1 h, and washed 5 times with PBST for 5 min each. Subsequently the cells were restained with DAPI and the expression of CD44, CD45, CD90 was observed by fluorescence microscope.

2.12. Statistical analysis

SPSS software was used for statistical analysis and graphing. A one-way ANOVA with post hoc Tukey's test was used for comparing multiple groups. Measurement data in each group are presented as a mean ± S.E.M (standard error of mean). P ≤ 0.05 was considered statistically significant. Graph was generated using Prism 6 (GraphPad).

3. Results

We identified the cultured husc by specific marker and found they expressed CD44 and CD90, but not CD45, which was consistent with the stem cell characteristics of husc in literature. Then the cell viability of husc was tested, and the data were as shown in Table 1 and Fig. 2. Morphologically, on day 2, day 4 and day 6, as well as the P3 generation cells were observed after the resuscitation of different urine cells. The husc were mainly adherent with spindle shaped, together with round, diamond, spindle and polygon partly (spherical, spindle, triangular) with the growth at day 6 in third passage (Fig. 1, Fig. 2, Fig. 3, Table 2).

Fig. 2.

Fig. 2

Cell viability test curve.

Fig. 1.

Fig. 1

Identification of human urine stem cells.

Fig. 3.

Fig. 3

Bright field images of different urine cells after resuscitation at 40 and 100 times.

Table 2.

Cell viability test results.

Cell viability test results
Total cell concentration 7.18E+05
Living cell concentration 6.96E+04
Dead cell concentration 2.22E+04
Live cell rate 96.91%
Mean cell size 14.19um
The dilution ratio 2
Cell agglomeration rate 2.105%

3.1. Behavioral data indicated by mNSS score

In order to verify the success of modeling, mNSS neurobehavioral evaluation was performed in each group at 1, 3, 5, 7, 10 and 14 days after surgery, respectively. SPSS was used for analysis, univariate measurement ANOVA was used for statistics and mapping, compared with the sham group, the neurological function in CIR rats was significant increase. Moreover, after injection of husc into the lateral ventricle, the neurological function was lower than that of CIR, which was statistically significant at day 14, and sphericity test and Greenhouse-Geisler was used, also. The data did not meet the sphericity hypothesis. Referring to the correction results of Greenhouse-Geisler, the results showed that both time and time*group had P < 0.05, suggesting differences in each time indicator variable,and the effect of treatment factors on index variables will change with the time. The comparison between groups and the test of inter-subject effect gives ANOVA of the treatment factor groups. P < 0.005 indicated that there was a difference in the amount of difference between different treatment groups. In addition, TTC stain confirmed the brain infarct was apparent increase, while it decreased significantly in the treatment of husc (Fig. 4A and B)

Fig. 4.

Fig. 4

Effect of CIR and husc treatment. A showed neural behavor. B–C showed TTC staining and quantitative analysis.

The effect of husc transplantation into cerebral ischemia-reperfusion was verified by bioassay. A total of 1493 genes were detected in Genecars for CIR. Some genes are shown in Table 3.

Table 3.

Repeat measure ANOVA table.

Repeat measure ANOVA table
Variables DF SS MF F P
Intervene 2 2306.271 1153.136 233.912 <0.001
Intergroup error 20 98.596 4.930
Time 2.943 141.833 48.193 91.143 <0.001
Time*Intervene 5.886 32.503 5.522 10.443 <0.001
Repeated measurement 58.861 31.123 0.529

Note: DF is the degree of freedom, SS is the sum of squares, MF is the mean square and P is the significance P-value.

A total of 1095 genes of human urine stem cells were found in Genecars. Some genes are shown in Table 4.

Table 4.

Some gene targets of CIR.

APP CBS KCNJ5 CASP1 NTRK2 TSPO ARID1B F8
KRIT1 SLC1A2 ADM F13A1 CTSD HTRA2 LPL IGFBP3
CST3 HMOX1 ODC1 ATP1A2 ITPR1 SLC9A1 EDNRA IL12A
F2 MMP9 CYCS AIFM1 FGB GPT EDNRB CCL3
IL6 SELE PDGFB ANGPT1 HGF SLC6A4 SMAD4 CCL5
TNF EPO NFE2L2 APOB TLR2 CSF1R RELA HSPB6
NOS3 SELP MAP2 PARP1 FOS PF4 TGFBR1 AIF1
COL4A1 S100B NPPA FAS HSPA8 PTGS1 ADA CHAT
ACE SOD2 TEK CSF3 MIR146A PRKCE MIR155 OCLN
F5 JAK2 TSC2 HSPA1A PPARG PRKAA2 ACTB CTSL
NOS2 MIR21 CASP9 AQP4 GLUL TOMM40 DRD2 HMGCR
ENG SERPINE1 GJA1 SLC6A3 CD40LG MIR34A TIMP3 PARK7
SOD1 CXCL8 FLT1 SPTAN1 DLG4 PDP1 MIR145 SPP1
MTHFR THBD PON1 G6PD EPRS1 REN PIK3CG MCU
ICAM1 CAT HSPA5 VCAM1 NPY PTK2B CDKN2A ACTG1
PIK3CA VWF AKT1 LTA SLC1A1 HP PPARA CACNA1B
MPO HSPA4 SHH MPL MIR210 SELL NLRP3 ABCB1
GAD1 ALB SNCA CR1 LMNA ADORA3 CDON MIR126
TP53 MB GRIN1 ACHE PECAM1 TNFRSF1A AGER AVP
VEGFA GRIN2B AGTR1 ADORA1 ATM IL17A FN1 PRKN
PTEN TGFB2 MAPK14 CALR ANGPT2 SYNGAP1 MYH7 MUC1
IL10 MMP2 IL18 ELANE TIMP1 MME CD40 SERPINA1
MEF2C IGF1 YRDC TXN LOX NGB CNR1 CKB
CASP3 ENO2 MTOR JUN FLNA HTR2A TTN ADCYAP1
PLAT NPPB SMARCAL1 CTLA4 SLC8A1 THBS1 STAT3 CPT2
SMARCA4 F3 PLG CP ERCC2 TGIF1 TNNI3 COMT
MAPT IL1RN ADAMTS13 EGF ANXA5 GDNF MIF ITGA2B
GFAP ACTA2 SLC2A1 ADRB2 ITGAM LAMB1 TNNT2 ADRB1
EDN1 SETD2 APOH IDH1 CTSB HSPG2 PCNA OLR1
PSEN1 SERPINA3 PROC LDLR PLAU MT-CO1 MBP BGN
SERPINC1 PLA2G6 EGR1 APOA1 NES RPS27A NFKB1 FMR1
TLR4 KDR IFNG HSPB1 SLC12A2 ADIPOQ XIAP NOL3
HIF1A PTGS2 VLDLR ALOX5 SMAD2 IL1A IL13 ENTPD1
PRNP BAX INS SLC17A5 EGFR NCF1 KCNMA1 SIRT1
CTNNB1 KNG1 AGT PROCR LEP CDKN3 ABCA1 SRC
IL1B SERPINI1 GRIN2A THPO NOTCH1 SH2B3 ITGB2 GLO1
COL3A1 CXCL12 ITGB3 PSAP BAD GAPDH PLA2G7 CA2
CRP GRIK2 HMGB1 FGA STAT1 VCP MAPK8IP1 ABCC8
COL4A2 GP1BA CALCA CLU IL2 AOC3 ITGB1 PRKG1
BCL2 PIK3C2A FGF2 NGF BCL2L1 SST CAMK2A TIE1
BDNF GSR IL4 MAPK8 ESR1 GSS TERT CFLAR
XDH CD36 ADORA2A TIMP2 IKBKG FGFR2 BMP6 PDE5A
NOS1 CDK5 MAPK1 MBL2 SMPD1 SDHB DNM1L MLC1

3.2. Venny diagram

The gene crossover between CIR and husc was analyzed, in which, 258 key targets of Venny diagram were obtained by deleting duplicates, as shown in Fig. 5.

Fig. 5.

Fig. 5

Venny diagram between CIR and husc. The left circle is the target gene from CIR, the right circle is the target gene from husc and the intersection target between them was acquire in the middle.

3.3. Cross genes were integrated with data from PubMed

For input key words CIR and husc in PubMed, respectively, Genes reported and unreported in crossest were screened and sorted into Excel tables. There are 258 intersection targets in the Venny diagram, among which, 6 genes have been reported and 252 genes have not been reported in PubMed, shown in Table 5, Table 6, Table 7, Table 8.

Table 5.

Partial gene targets of husc.

IL6 MUC4 UBA1 ACO1 NPHP3 EEF1G SPPL2A PROM2
KRAS IGFBP2 PPT1 MGAT5 CDH16 DDAH1 CAPN7 FUCA2
TERT C3 LAMP1 GNB3 PPT2 NID2 IST1 SECTM1
BRAF NEU1 IRAK1 SERPINB9 LBP LTBP2 KRT75 MYL6B
CD44 ANXA2 DMBT1 AQP2 CCT4 ANXA3 TUBB8 PEF1
CXCL12 TXN TPI1 ACTR2 ACTN3 ATP6V1A PYGB STK25
FGFR3 YWHAE NECTIN2 DKK3 CFD H4C12 SERPINA6 H2AC16
ITGB1 STXBP2 MYH10 GPI UMOD COTL1 ARHGAP1 EHD4
CDH1 PLA2G2A KL SDCBP EPX STK26 MGAT1 LRRC57
FGF2 MMP7 HNRNPK APRT BAIAP2L1 UPK1A CLEC3B GATM
IL1B SERPINA1 MTHFD1 ARF1 C8B CFB GNG4 C8A
CASP8 LGALS1 ARSB FAT4 NPHS2 CA1 RAB21 MAN1C1
EGF TUBB H4-16 HNRNPM SERPINF2 CACNA2D1 FIGNL1 DOP1B
FASLG DNASE1 RDX CETP SLC12A1 NIBAN1 RAB11B VPS25
MIR21 APOB COL18A1 FGB GSTM3 PYGM TBC1D10A GMPPA
CASP3 AQP1 CFL1 HMCN1 VPS4B UGP2 SMS PSMA8
PPARG IGF2R GP1BA APOH TUBB6 TXNDC5 PLPP1 H2AC17
ENG FCGR3B ARF6 CKB FSHB CAND1 ENO3 NUCB1
VCAM1 KLK3 PGK1 ENPEP ATP5F1B SERPINB8 ATP6V1B1 RAB5B
PROM1 KNG1 IGHG1 RBP4 SDCBP2 PACSIN3 NAPRT PGM2
ABCB1 DMD GAS6 FABP5 APOA2 PSMB2 ANXA7 GPD1L
HBB CP HSP90AB1 EFNB1 MACROH2A1 WASF3 CPVL TNXA
FN1 PTPRJ ACTG2 CSTB MYOF BASP1 COL15A1 PTTG1IP
CD36 CLTC MB LAMB2 SERPIND1 SERPING1 ACTR1A ENTPD2
THY1 RPS27A TLN1 GLO1 NIBAN2 GPLD1 LAP3 SPR
MMP9 KRT13 C5 HSPA1B HPN GLG1 FAM3C MYO5C
EPCAM TTR LRP2 BST1 SFRP4 MYO1D ATP6V0D1 H2AC6
MUC1 ACP1 CANX GPX3 HRG UPK3A GCA RNASE2
NF1 HBA2 YWHAZ PRDX6 SELENOP APCS ARF3 ALDH1L2
ALB RAB27A LAMA5 MYO1C ALDH9A1 ADH5 VPS4A GUCA2B
RAC1 PRKACA DAG1 AHCY LILRB4 SUSD2 MXRA8 PPIC
MMP2 GSN FGA PIGR GM2A BTD SULT2B1 H2AC13
SOD1 LAMA3 CNP ALOX15B GC H2AZ1 AKR1C4 PLBD2
ANPEP RXRA IGFBP7 HPR CST6 SORD PROZ MON2
SPP1 CFH CD177 CLIC1 C1R PAICS QDPR CTSZ
LHCGR PODXL CDH11 UBA52 MDH1 PAM MLPH NAAA
B2M PRDX1 GGT1 AKR1C3 RHOG H4C2 ACP2 CUTA
EDN1 KRT1 IGHM ANO6 FBLN5 LTA4H LUM GSTT2
NT5E PLG COL4A2 PGM1 DSC1 MPI H2AC4 CNDP2
SMO ANXA1 CHI3L1 NID1 ARPC3 SERPINI1 DNPH1 XPNPEP1
ACTB SERPINF1 CST3 FUCA1 PSME2 NPEPPS AKR7A2 ATRN
CASP9 KRT20 CHL1 PSMA7 TUBB4B H2AC20 CPNE2 ABHD14B
FCGR3A SFN PABPC1 GANAB ACLY SPON2 AOC1 BDH2

Table 6.

Cross gene between CIR and husc.

CST3 ENO2 TXN PLAU ABCB1 GOT2 CDC42
F2 ACTA2 CP SMPD1 MUC1 TF LTF
IL6 SERPINA3 EGF HP SERPINA1 C4A ITGAV
ACE KNG1 IDH1 MME CKB ACTC1 EPX
ENG SERPINI1 APOA1 THBS1 COMT SERPINF2 FABP1
SOD1 CXCL12 HSPB1 HSPG2 BGN LRP2 PRDX1
MPO GP1BA PROCR RPS27A GLO1 FASLG GGT1
CASP3 GSR PSAP GAPDH SOD3 CTSG SERPINA4
EDN1 CD36 FGA VCP AQP1 NT5E CD55
SERPINC1 CASP9 CLU GSS PROS1 HSP90AA1 SERPINF1
IL1B PON1 CTSD ACTB PLA2G2A GDF15 TKT
COL4A2 PLG FGB FN1 COL18A1 RETN NID1
MMP9 APOH HSPA8 MIF AKR1B1 LGALS3 AHSG
SOD2 AGT MIR146A ITGB1 RAC1 ACE2 PTGDS
MIR21 FGF2 PPARG TERT LCN2 NAXE GNA11
CAT APOB TIMP1 FABP3 C3 PNP CD14
ALB HSPA1A FLNA CTSL NAGLU SLC9A3R2 CHI3L1
MB G6PD ANXA5 PARK7 CASP8 ACP1 C5
MMP2 VCAM1 ITGAM SPP1 CFH KL ALDH9A1
ELANE CR1 CTSB ACTG1 IGFBP2 CD44 AOC1
KRT18 GUSB AXL PPIA CD38 MYH10 LIFR
DNM2 S100A8 MGAM MASP2 HMCN1 THY1 APOC3
VTN GPX3 PROM1 LDHA PSMA7 ENTPD2 S100A9
GSTP1 C1R LRG1 ALDOA YWHAZ UBE2D3 HPX
ENO1 AGRN TNXB HSPA1B SELENOP ATP5F1A APRT
CAPN1 NEU1 TPI1 GSTA2 HSP90AB1 DBI IL6ST
NAMPT APOD RNASE3 SI PRDX6 WWP2 LBP
CA1 FCGR3A F12 PRKACA ENO3 ACTA1 COL6A1
CRYAB EPHX2 PLSCR1 CANT1 SAA4 HRG NPR3
FCGR3B H2AX A2M GSTT1 DDAH2 ACTN4 GC
CD59 CPB2 DDAH1 IGFBP7 FASN LAP3 ANXA7
DES IRAK1 CEACAM1 COL6A3 CFB GSTM3 AMBP
DPP4 EEF2 GOT1 CLEC3B UMOD VPS28 SERPING1
PTPA TOLLIP LGALS1 LAMC1 SFN FSTL1 PRDX2
B2M CUBN PRDX5 LAMB2 CEACAM5 CBR1 ITCH
TGM2 ANXA2 SAA1 FABP4 PEPD SELENBP1 SLC3A2
ANXA1 IQGAP1 VDAC1 THBS4 DEFA1 ART3

Table 7.

Gene name reported in PubMed.

IL6 IL1B MPO
SOD1 MMP9 CAT

Table 8.

Genes unreported in PubMed.

No gene list was reported after query
CST3 ENO2 TXN PLAU ABCB1 GOT2 CDC42
F2 ACTA2 CP SMPD1 MUC1 TF LTF
ACE SERPINA3 EGF HP SERPINA1 C4A ITGAV
ENG KNG1 IDH1 MME CKB ACTC1 EPX
CASP3 SERPINI1 APOA1 THBS1 COMT SERPINF2 FABP1
EDN1 CXCL12 HSPB1 HSPG2 BGN LRP2 PRDX1
SERPINC1 GP1BA PROCR RPS27A GLO1 FASLG GGT1
COL4A2 GSR PSAP GAPDH SOD3 CTSG SERPINA4
SOD2 CD36 FGA VCP AQP1 NT5E CD55
MIR21 CASP9 CLU GSS PROS1 HSP90AA1 SERPINF1
ALB PON1 CTSD ACTB PLA2G2A GDF15 TKT
MB PLG FGB FN1 COL18A1 RETN NID1
MMP2 APOH HSPA8 MIF AKR1B1 LGALS3 AHSG
ELANE AGT MIR146A ITGB1 RAC1 ACE2 PTGDS
AOC1 FGF2 PPARG TERT LCN2 NAXE GNA11
S100A9 APOB TIMP1 FABP3 C3 PNP CD14
IL6ST HSPA1A FLNA CTSL NAGLU SLC9A3R2 CHI3L1
NPR3 G6PD ANXA5 PARK7 CASP8 ACP1 C5
AMBP VCAM1 ITGAM SPP1 CFH KL ALDH9A1
CR1 CTSB ACTG1 IGFBP2 CD44 MYH10 TGM2
KRT18 GUSB AXL PPIA CD38 THY1 ANXA1
DNM2 S100A8 MGAM MASP2 HMCN1 ENTPD2 LIFR
VTN GPX3 PROM1 LDHA PSMA7 UBE2D3 APOC3
GSTP1 C1R LRG1 ALDOA YWHAZ ATP5F1A ANXA2
ENO1 AGRN TNXB HSPA1B SELENOP DBI IQGAP1
CAPN1 NEU1 TPI1 GSTA2 HSP90AB1 WWP2 HPX
NAMPT APOD RNASE3 SI PRDX6 ACTA1 APRT
CA1 FCGR3A F12 PRKACA ENO3 HRG SAA1
CRYAB EPHX2 PLSCR1 CANT1 SAA4 ACTN4 VDAC1
FCGR3B H2AX A2M GSTT1 DDAH2 LAP3 LBP
CD59 CPB2 DDAH1 IGFBP7 FASN GSTM3 COL6A1
DES IRAK1 CEACAM1 COL6A3 CFB VPS28 FABP4
DPP4 EEF2 GOT1 CLEC3B UMOD FSTL1 THBS4
PTPA TOLLIP LGALS1 LAMC1 SFN CBR1 GC
B2M CUBN PRDX5 LAMB2 CEACAM5 SELENBP1 ANXA7
SLC3A2 PRDX2 SERPING1 ITCH DEFA1 ART3 PEPD

3.4. The GO analysis

We analyzed the mechanism of husc to improve CIR. The top 10 biological processes (BP) involved in GO enrichment analysis are as follows: Neutrophil activation involved in immune response, neutrophil degranulation, Hemostasis, blood coagulation, negative regulation of coagulation, regulation of coagulation endopeptidase, and activity regulation of Peptidase activity. The top 10 factors involved in cell component (CC) in GO enrichment analysis were: Vesicle Lumen, Cytoplasmic Vesicle Lumen, Secretory Granule Lumen, Collagen −containing extracellular matrix, blood Microparticle, vacuolar Lumen, platelet alpha granule lumen, platelet alpha granule, endoplasmic reticulum Lumen, Ficolin −1− Rich Granule. The top 10 factors involved in molecular function (MF) in GO enrichment analysis were enzyme inhibitor activity, Endopeptidase inhibitor activity and Peptidase regulator Activity, Peptidase inhibitor activity Endopeptidase regulator activity, Sulfur compound binding, Glycosaminoglycan binding, Antioxidant activity, Heparin Binding, Extracellular matrix structural constituent and Protease binding, shown in Fig. 6. Fig. 6 shows that BP participates in many biological processes, among which, neutrophil degranulation is the most abundant biological process. Neutrophil activation involved in immune response, and platelet degranulation. These biological processes constitute an important part of cell development. CC involves many cellular components, among which Vesicle Lumen is the most important chemical component, followed by Cytoplasmic Vesicle Lumen and Secretory granule Lumen, which constitute cellular components related to cell development. MF involves many molecular characteristics, among which enzyme inhibitor activity is one of the most important, followed by endopeptidase inhibitor activity, Peptidase regulator activity, these molecules constitute molecular functions related to cell development (Fig. 6A–C).

Fig. 6.

Fig. 6

Enrichment diagram of GO analysis. A. Biological processes (BP), B. Cellular components (CC) and C are involved in enrichment analysis. Top 20 factors of molecular function (MF).

3.5. KEGG pathway analysis

To elucidate the mechanism of husc in CIR, we analyzed the KEGG pathway after gene crossover (Fig. 7). The results showed that the top 10 pathways in KEGG pathway were: Complement and coagulation cascades, ECM-receptor interaction, Glutathione metabolism, Proteoglycans in Cancer, Legionellosis, Lipid and atherosclerosis, Staphylococcus aureus infection, Amoebiasis, Fluid shear stress and atherosclerosis.

Fig. 7.

Fig. 7

Analysis of KEGG pathway.

3.6. PPI protein network construction

252 intersecting genes not reported in Table 5 were selected to performed String (https://string-db.org/). After UniProt Transformation, protein interaction network analysis can understand intermolecular interactions and protein interaction network diagrams. As shown in Fig. 8, Each node represents a protein target, and each connector represents the interaction between two target proteins. The larger the node, the higher the centrality of the protein target, the thicker the connecting line, and the stronger the interaction between the two proteins. Especially, it can be seen that there are many histones and there are complex relationships among genes, which is mainly in a circular concentrated in the middle of the protein. In addition, there is a protein relationship formed at the upper right, and is also a small amount of protein in the upper and lower left could be seen.

Fig. 8.

Fig. 8

PPI network of genes interaction.

3.7. Core gene recognition

After PPI protein was analyzed by 252 unreported intersection genes, and protein interaction table was derived, ten Hub genes were screened out according to Degree value in Cytoscape, in which CD44, ACTB, FN1,ITGB1, PLG, CASP3, ALB, HSP90AA1, EGF, GAPDH were noticed(Fig. 9)

Fig. 9.

Fig. 9

The Hub genes.

3.8. qRT-PCR findings

We used qRT-PCR to evaluate the effect of husc in CIR improvement. The results showed that the mRNA expression of ACTB, ALB, CASP3, CD44, ITGB1, FN1, PLG and GAPDH were higher in the CIR group than in the sham group. Comparing after the treatment of husc, the mRNA expression of ACTB, ALB, CASP3, CD44, ITGB1 and GAPDH were decreased related to the CIR group. Whereas, the mRNA expression of FN1 and PLG were higher in the hUSCs group than in the CIR group. Moreover, the mRNA expression level of EGF was decreased in the CIR group compared with that in the sham group, but upregulated in after the treatment of hUSCs, than that of the CIR group (Fig. 10).

Fig. 10.

Fig. 10

The relative mRNA expression of CD44, ACTB, FN1, ITGB1, PLG, CASP3, ALB, HSP90AA1, EGF and GAPDH in the sham, CIR and husc group.

4. Discussion

We conducted animal experiments to verify that husc can improve the neural function in CIR rats, and analyzed the gene network changes after CIR treated with cells transplantation, combined with bioinformatics. We looking for cross-genes from Genecars [16]. Combined with Venny analysis, and integrated reported and unreported genes in PubMed and CNKI. 252 key genes unreported we performed protein interaction of GO, KEGG and PPI. According to GO enrichment [17], neutrophil degranulation is crucial in BP, vesicle Lumen is an important process of cell composition. Neutrophil degranulation is modulated by cell transplantation during cerebral ischemia. In addition, neutrophil degranulation and neutrophil activation involved in immune response are the terms with the largest number of BP enrichment in our analysis, and enzyme activity is the term with the largest number of MF rich sets. From KEGG pathway analysis, we can see that complement and coagulation cascades is the most important pathway. Importantly, hub gene included CD44, ACTB, FN1, ITGB1, PLG, CASP3, ALB, HSP90AA1, EGF, and GAPDH, was confirmed by q-PCR.

4.1. Neurological improvement after husc treatment

As husc can be obtained in a non-invasive way (Bento, Shafigullina et al., 2020), it has a potential for the treatment of CIR. In this study, we found that husc transplanted into the lateral ventricle can improve the neurological function in husc treated group at day 14. Literaturely, Liang reported that exosomes from husc enhanced cell proliferation and neuronal differentiation via miR-26a/HDAC6 axis in vitro neural stem cells model of ischemic stroke which were treated with oxygen-glucose deprivation/reoxygenation [18]. Wu found that transplantation of neural progenitor cells induced from husc can significantly improve neurological functions with migration of cells from the grafted side to the lesion side in stroke rats undergoing transient middle cerebral artery occlusion (tMCAO) reperfusion [19]. Zhang reported that MicroRNA-216a-5p from exosomes secreted by husc ameliorate ischemia/reperfusion injury through decreasing PTEN levels and stimulating Akt phosphorylation in HK-2 cells [20]. In addition, the beneficial potential of husc can be improved by genetic modifications has been reported, suggesting husc can be considered as a cell vector that could help gene therapy (Salehi, MS,. et al. (2022). Tegother, the effect of husc in improving neurological function after brain ischemia is certain in these observations. Gene network and its functional implication.

With the rapid development of modern medicine, stem cell transplantation is considered to have great potential in treating neurological diseases, including stroke. Literature has found that MSC can treat cerebral ischemia and prevent inflammation of glial cells induced by cerebral ischemia by inhibiting TLR4 [21]. Compared to other stem cells, husc possess several [22]. The collection method from human urine is simple, non-invasive, reproducible and acceptable, and avoids the ethical issues raised by the use of other tissues. Though there has report in husc promoting stroke recovery [23], the molecular network mechanism of husc therapy for stroke is unclear. This paper is the first report and show the molecular network mechanism of husc in CIR, according to gene network relationship [24].

4.2. Were integrated unreported genes to get core genes

So far, the commonly used strategy of bioinformatics is to query targets in the database. Due to the timeliness of genes, previous research summaries reported, but the latest PubMed literature results are not included. Therefore, we specially supplemented the latest literature results related to husc. Compared with the results of intersection, 252 intersecting genes that had never been reported in literature. This therefore provides important gene network for stem cell therapy by different data integration. Implication of GO enrichment and KEGG pathway analysis.

GO enrichment analysis showed that neutrophil degranulation was crucial in BP. Neutrophils can become inflammatory and infected [25]. According to the literature, after CIR, neutrophils will accumulate in the pia meningeal and perivascular space, and eventually reach the infarcted brain parenchyma [26]. In the co-expression module, the lumen is an important process of cell composition. Endodermal vesicles are the best spatial and temporal indexes [27]. In addition, enzyme inhibitor activity was the term with the largest number of MF concentrations in our analysis [28]. Activity of enzyme inhibitors may alleviate neuronal damage caused by ischemic stroke [29].

KEGG pathway analysis showed that the treatment of CIR by husc involved the first ten signaling pathways: included Complement and coagulation cascades, ECM-receptor interaction, Glutathione metabolism, Proteoglycans in cancer, Legionellosis, Focal adhesion, Lipid and atherosclerosis, Staphylococcus aureus infection, Amoebiasis, Fluid shear stress and atherosclerosis [30]. The metabolic network we constructed will help to select molecular targets and elucidate the molecular mechanisms of cerebral ischemia [31]. Complement and coagulation cascade are the most important pathways in KEGG. When adjust is the highest, Count is the highest, therefore differential expression is the most significant. It is believed to be closely related to the treatment of CIR by huscl transplantation and may be involved in its occurrence and progression [32]. In complement and coagulation cascade signaling, coagulation cascade is used to target proteolysis on the surface of activated platelets. If platelets are activated by exposure to an activated endothelium, they are released to promote the formation of microvesicles that bind to platelet adhesion mediators, clotting factors, and adjacent receptors on the membrane, hydrolysis of the proenzyme cascade proteins into active enzymes, and thrombin production [33]. The occurrence of coagulation cascade may promote cerebral ischemia through thrombin [30]. In the ECM-receptor interaction signaling pathway, ECM-receptor interaction may promote the formation of husc. In glutathione metabolic signaling pathways, glutathione can be exported and imported through the plasma membrane of many cells [34]. Glutathione metabolism plays a role in shaping the immune microenvironment [35]. Among the proteoglycan signaling pathways in cancer, proteoglycan inhibits effectively tumor growth in cancer [36],In the Legionnaires' disease signaling pathway, legionnaires' disease may be a pathogen produced after husc transplantation [37]. An important step in cell migration is adhesion to the substrate with specific adhesion points in the adhesion spot signaling pathway [38]. In the lipid and atherosclerotic signaling pathways, atherosclerosis, as a chronic inflammation of the artery wall, is widespread, which is presenting damage and plaque accumulation in the intima of the artery wall. At the same time, plaque erosion and rupture can lead to blood clots, and atherosclerosis may develop in the brain after their cells are transplanted [39].

Staphylococcus aureus infections in the signal path, staphylococcus aureus, as a kind of symbiotic organism infection, may be accompanied by anthropogenic urine infection occurs in the process, stem cell transplants in amoebiasis signaling pathways, amoebiasis was dissolved in the organization amoebic caused in the gut of native animal diseases, the anthropogenic urine amoebiasis disease may occur after stem cell transplantation. Fluid shear stress induces apoptosis of husc in both fluid shear stress and atherosclerotic signaling pathways, and atherosclerosis may lead to thrombosis in cerebral ischemia [40].

4.3. Protein interaction and its significance

This paper analyzes the network interaction between CIR and various proteins expressed in husc [41,42]. As you can see, there are a lot of histones, mainly in a round cluster of proteins in the middle. Secondly, there is a protein relationship formed at the upper right, including a small amount of protein in the upper and lower left. Among them, CPB2, APOH, MIF, CTSG, TIMP1, MMP2, VTN, APOC3, GAPDH and HRG are the most important proteins [43]. Among the 10 most important proteins, there are close connections between each protein. In addition to the strong interaction between the above proteins, DDAH2 and DDAH1 in the lower left corner and IL6 ST in the lower right corner have direct interaction with LIFR. These proteins may indicate the stage of CIR interaction with husc, suggesting these molecular network interpretations play an important role in husc transplantation during cerebral ischemia reperfusion. Literature has shown that husc contribute to functional recovery of cerebral ischemia, and their molecules are regulated by mulfiple genes [44]. In this study, we reported the effect of huse in CIR and revealed the core gene network. Hub gene found mag include: CD44, ACTB, FN1, ITGB1, PLG, CASP3, ALB, HSP90AA1, EGF, GAPDH. We predict that these 10 genes have a regulatory role in CIR.

4.3.1. qRT-PCR validated the gene expression and its functional implication

In this study, we confirmed the multiple gene change in husc treated CIR. Of these, CD44, a transmembrane glycoprotein, known to be involved in regulation of cytokine gene expression, lymphocyte trafficking and endothelial cell recognition in inflammatory diseases, has been involved in our observation. Previously, it is has been reported that CD44 expression was inhibited when SD rats with cerebral ischemia-reperfusion injury were treated with Leonuri Herba Total Alkali [45]. This indirectly indicated that CD44 is up-regulated in CIR and may be involved in the occurrence and development of CIR. Similarly, Wang X et al. found that [46] the expression of CD44 mRNA was induced in a mouse model of cerebral ischemia.

Act-β has been recognized as the most stably expressed endogenous genes, [47]. Moreover, GAPDH, a glycolytic enzyme, was also used as the endogenous gene. However, Li C et al. pointed out that [48] GAPDH shared S-nitroylation, Siah1 binding, translocation to nucleus, and concomitant neuron death occur during the early stages of reperfusion in the rat four-vessel occlusion ischemic model. Similarly, over-expression of GAPDH in nucleus resulted in neuronal apoptosis induced by CIR [49]. Here, we showed the change of β-actin and GADPH after CIR with husc treatment may have some indicationssimilar to past finding of GADPH in CIR.

Fibronectin 1 (Fn1) was markedly elevated in the heart of I/R pigs and ischemic patients and inhibition of Fn1 may be a novel therapeutic option for treating ischemic heart diseases [50]. Nevertheless, there was no experimental research reported the role of Fn1 in CIR. Thus, we speculated Fn1 was upregulated in CIR with husc treatment condition, indicating this molecule mas been involved in our observation.

Integrin β1 played a key role in the repair and protection of neurovascular units by promoting angiogenesis In the process of CIR. The inhibition of Integrin β1 pathway during CIR aggravated the behavior and neurovascular regeneration of CIR rats [51]. These evidences indicated that Integrin β1 was downgraded in CIR. Our study reported the expression of integrin β1 was downregulated in CIR after husc treatment, supplying the novel evidence to understand the role of integrin β1 in CIR with husc treatment.

In clinical settings, tissue plasminogen activator (t-PA) for thrombolytic therapy is the most important thrombolytic drug of ischemic stroke and has neuroprotective effects [52]. Some research found that [53] tPA knocking out significantly aggravated brain injury and increased neuronal apoptosis and mitochondrial damage, which indicated that tPA may inhibit apoptosis and improve mitochondrial function. In addition, accumulating evidence has suggested that [54,55] apoptosis played an important role in the occurrence and development of CIR, corresponding to the increase of Caspase3. Whereas, Albumin (ALB), a potent antioxidant [56] had neuroprotective effects on cerebral hemorrhage, focal and global cerebral ischemia and subarachnoid hemorrhage [57]. In particular, ALB administration abated neuronal apoptosis after cerebral hemorrhage at least in part through the ERK/Nrf2/HO-1 signaling pathway [57]. Comparatively, literature report, we just found the expression of AIB and caspase-3 in CIR subjected to husc treatment, suggesting effect of husc in CIR may be derived the inhibition of these genes.

Oppositely, one study suggested that [58] epidermal growth factor (EGF) had protective effects on ischemic injury via activating EGF receptor (EGFR). Further, EGF/EGFR activation ameliorated infarct volume of brain tissues and neurological deficit. Moreover, Tang Y et al. pointed out that [59] EGF pretreatment significantly decreased neurological deficit and infarct volume. In addition, EGF pretreatment increased the expression of Bcl-2 and reduced the expression of Bax. These evidences indicated that EGF protect against apoptosis, neurological deficit and infarct in CIR.

Ma D et al. suggested that [60] HSP90AA1 might be related to the pathogenesis of I/R injury via weighted gene co-expression network analysis. However, the role of HSP90AA1 in CIR-induced injury is not well illustrated. In our study, we reported EGF decreased after CIR but reversed in husc administered condition, indicating EGF is a crucial molecue in CIR with husc addition, which is largely different form the HSP90AA1, with no change in this study.

5. Conclusion

It can conclude that husc transplantation improve effectively neural behavior in CIR rats, and the underlying mechanism is involving multiple genes, in which, ALB, caspase-3, CD44, ITGB1, even ACTB, and GADPH was significantly increased in CIR and decreased in husc treatment. All of these findings could provide novel evidences in molecular network to understand the effect of husc in CIR treatment.

Ethical approval

All procedures were performed in accordance with the guidelines and approval of the Ethics Committee of the Kunming Medical University, and approved by the Animal Experiment Ethics Committee of Kunming Medical University, with number KMMU20220891.

Human and animal ethics

The Ethical approval number for the husc extraction, is YLS2021-55, white the animal ethics code is KMMU20220891.

Public consent

I declared that all authors agree to publish.

Whether there is supporting data

I declared that the data and materials contained in this manuscript have not been published elsewhere and are available.

Raw data declaration

I declare that all original data are contained in this manuscript and attached materials without reservation, and that the data and materials contained in this manuscript have not been published elsewhere.

CRediT authorship contribution statement

Lang-Chun Zhang: Writing – review & editing, Writing – original draft. Na Li: Methodology, Data curation. Ji-Lin Chen: Data curation. Jie Sun: Resources. Min Xu: Data curation. Wen-Qiang Liu: Data curation. Zhong-Fu Zuo: Data curation. Lan-Lan Shi: Data curation, Conceptualization. Ting-Hua Wang: Visualization, Funding acquisition. Xiang-Yin Luo: Writing – review & editing, Methodology.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

This study was supported by General Project of Joint Special Fund for Applied Basic Research of Yunnan Science and Technology Department and Kunming Medical University in 2019, Project No. 2019FE001 (−025), This study was supported by National Science Foundation Project No. 3000227.

Contributor Information

Lang-Chun Zhang, Email: zhlch-2010@163.com.

Ting-Hua Wang, Email: wangtinghua@vip163.com.

Xiang-Yin Luo, Email: Luoxiangying1978@csu.edu.cn.

References

  • 1.Guo P., et al. Effects of irisin on the dysfunction of blood-brain barrier in rats after focal cerebral ischemia/reperfusion. Brain Behav. 2019;9(10) doi: 10.1002/brb3.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shen Z., et al. PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window. Autophagy. 2017;13(3):473–485. doi: 10.1080/15548627.2016.1274596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Li S., et al. Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 2021;54(8) doi: 10.1111/cpr.13093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Doeppner T.R., Hermann D.M. Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities. Stem Cells Cloning. 2010;3:157–163. doi: 10.2147/SCCAA.S7820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huang Y., et al. CUEDC2 ablation enhances the efficacy of mesenchymal stem cells in ameliorating cerebral ischemia/reperfusion insult. Aging (Albany NY) 2021;13(3):4335–4356. doi: 10.18632/aging.202394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boese A.C., et al. Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res. Ther. 2018;9(1):154. doi: 10.1186/s13287-018-0913-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Choi J.Y., et al. Potency of human urine-derived stem cells for renal lineage differentiation. Tissue Eng Regen Med. 2017;14(6):775–785. doi: 10.1007/s13770-017-0081-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zhou T., et al. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 2012;7(12):2080–2089. doi: 10.1038/nprot.2012.115. [DOI] [PubMed] [Google Scholar]
  • 9.Ji X., et al. Urine-derived stem cells: the present and the future. Stem Cells Int. 2017;2017 doi: 10.1155/2017/4378947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wu R., et al. Functional characterization of the immunomodulatory properties of human urine-derived stem cells. Transl. Androl. Urol. 2021;10(9):3566–3578. doi: 10.21037/tau-21-506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hwang Y., et al. Direct differentiation of insulin-producing cells from human urine-derived stem cells. Int. J. Med. Sci. 2019;16(12):1668–1676. doi: 10.7150/ijms.36011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Huang Y.Z., et al. Tissue Eng Part B Rev; 2022. Urine-Derived Stem Cells for Regenerative Medicine: Basic Biology, Applications, and Challenges. [DOI] [PubMed] [Google Scholar]
  • 13.Wang C., et al. RNA-seq based transcriptome analysis of endothelial differentiation of bone marrow mesenchymal stem cells. Eur. J. Vasc. Endovasc. Surg. 2020;59(5):834–842. doi: 10.1016/j.ejvs.2019.11.003. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang Y.F., et al. Systematic elucidation of the mechanism of geraniol via network pharmacology. Drug Des. Dev. Ther. 2019;13:1069–1075. doi: 10.2147/DDDT.S189088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang R., et al. Salt-inducible kinase 2 regulates energy metabolism in rats with cerebral ischemia-reperfusion. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50(3):352–360. doi: 10.3724/zdxbyxb-2021-0164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Safran M., et al. vol. 2010. Database; Oxford: 2010. GeneCards Version 3: the Human Gene Integrator; p. baq020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang H., Zheng H., Chen D.Z. IEEE/ACM Trans Comput Biol Bioinform; 2022. TANGO: A GO-Term Embedding Based Method for Protein Semantic Similarity Prediction. [DOI] [PubMed] [Google Scholar]
  • 18.Ling X., et al. Exosomes from human urine-derived stem cells enhanced neurogenesis via miR-26a/HDAC6 axis after ischaemic stroke. J. Cell Mol. Med. 2020;24(1):640–654. doi: 10.1111/jcmm.14774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wu R., et al. Transplantation of neural progenitor cells generated from human urine epithelial cell-derived induced pluripotent stem cells improves neurological functions in rats with stroke. Discov. Med. 2020;29(156):53–64. [PubMed] [Google Scholar]
  • 20.Zhang Y., et al. Transfer of MicroRNA-216a-5p from exosomes secreted by human urine-derived stem cells reduces renal ischemia/reperfusion injury. Front. Cell Dev. Biol. 2020;8 doi: 10.3389/fcell.2020.610587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cai G., et al. Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction. Stem Cell Res. Ther. 2021;12(1):2. doi: 10.1186/s13287-020-02030-w. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 22.Pavathuparambil Abdul Manaph N., et al. Urine-derived cells for human cell therapy. Stem Cell Res. Ther. 2018;9(1):189. doi: 10.1186/s13287-018-0932-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Artegiani B., et al. A single-cell RNA sequencing study reveals cellular and molecular dynamics of the hippocampal neurogenic niche. Cell Rep. 2017;21(11):3271–3284. doi: 10.1016/j.celrep.2017.11.050. [DOI] [PubMed] [Google Scholar]
  • 24.Fishilevich S., et al. vol. 2017. Database; Oxford: 2017. GeneHancer: Genome-wide Integration of Enhancers and Target Genes in GeneCards. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mollinedo F. Neutrophil degranulation, plasticity, and cancer metastasis. Trends Immunol. 2019;40(3):228–242. doi: 10.1016/j.it.2019.01.006. [DOI] [PubMed] [Google Scholar]
  • 26.Otxoa-de-Amezaga A., et al. Location of neutrophils in different compartments of the damaged mouse brain after severe ischemia/reperfusion. Stroke. 2019;50(6):1548–1557. doi: 10.1161/STROKEAHA.118.023837. [DOI] [PubMed] [Google Scholar]
  • 27.Haley M.J., Lawrence C.B. The blood-brain barrier after stroke: structural studies and the role of transcytotic vesicles. J. Cerebr. Blood Flow Metabol. 2017;37(2):456–470. doi: 10.1177/0271678X16629976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Alatan H., et al. Extracellular matrix-related hubs genes have adverse effects on gastric adenocarcinoma prognosis based on bioinformatics analysis. Genes. 2021;12(7) doi: 10.3390/genes12071104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Min J.W., et al. USP14 inhibitor attenuates cerebral ischemia/reperfusion-induced neuronal injury in mice. J. Neurochem. 2017;140(5):826–833. doi: 10.1111/jnc.13941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Xie Y., et al. Revealing the mechanism of astragali radix against cancer-related fatigue by network pharmacology and molecular docking. Evid Based Complement Alternat Med. 2021;2021 doi: 10.1155/2021/7075920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liu M., et al. An evidence-based review of related metabolites and metabolic network research on cerebral ischemia. Oxid. Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/9162074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fang X., et al. Enrichment analysis of differentially expressed genes in chronic heart failure. Ann. Palliat. Med. 2021;10(8):9049–9056. doi: 10.21037/apm-21-1854. [DOI] [PubMed] [Google Scholar]
  • 33.Green D. Coagulation cascade. Hemodial. Int. 2006;10(Suppl 2):S2–S4. doi: 10.1111/j.1542-4758.2006.00119.x. [DOI] [PubMed] [Google Scholar]
  • 34.Oestreicher J., Morgan B. Glutathione: subcellular distribution and membrane transport (1) Biochem. Cell. Biol. 2019;97(3):270–289. doi: 10.1139/bcb-2018-0189. [DOI] [PubMed] [Google Scholar]
  • 35.Xiao Y., Meierhofer D. Glutathione metabolism in renal cell carcinoma progression and implications for therapies. Int. J. Mol. Sci. 2019;20(15) doi: 10.3390/ijms20153672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wei J., et al. Roles of proteoglycans and glycosaminoglycans in cancer development and progression. Int. J. Mol. Sci. 2020;21(17) doi: 10.3390/ijms21175983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mikulska M., et al. Legionellosis after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021;56(10):2555–2566. doi: 10.1038/s41409-021-01333-7. [DOI] [PubMed] [Google Scholar]
  • 38.Paluch E.K., Aspalter I.M., Sixt M. Focal adhesion-independent cell migration. Annu. Rev. Cell Dev. Biol. 2016;32:469–490. doi: 10.1146/annurev-cellbio-111315-125341. [DOI] [PubMed] [Google Scholar]
  • 39.Poznyak A., et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 2020;21(5) doi: 10.3390/ijms21051835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rennier K., Ji J.Y. The role of death-associated protein kinase (DAPK) in endothelial apoptosis under fluid shear stress. Life Sci. 2013;93(5–6):194–200. doi: 10.1016/j.lfs.2013.06.011. [DOI] [PubMed] [Google Scholar]
  • 41.Zhou J., et al. Protein function prediction based on PPI networks: network reconstruction vs edge enrichment. Front. Genet. 2021;12 doi: 10.3389/fgene.2021.758131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Vella D., et al. MTGO: PPI network analysis via topological and functional module identification. Sci. Rep. 2018;8(1):5499. doi: 10.1038/s41598-018-23672-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.He W.Q., et al. The PPI network and clusters analysis in glioblastoma. Eur. Rev. Med. Pharmacol. Sci. 2015;19(24):4784–4790. [PubMed] [Google Scholar]
  • 44.Pan W., et al. Human urine-derived stem cell-derived exosomal miR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis. Lab. Invest. 2021;101(7):824–836. doi: 10.1038/s41374-021-00574-w. [DOI] [PubMed] [Google Scholar]
  • 45.Li Y., et al. Protection against acute cerebral ischemia/reperfusion injury by Leonuri Herba Total Alkali via modulation of BDNF-TrKB-PI3K/Akt signaling pathway in rats. Biomed. Pharmacother. 2021;133 doi: 10.1016/j.biopha.2020.111021. [DOI] [PubMed] [Google Scholar]
  • 46.Wang X., et al. CD44 deficiency in mice protects brain from cerebral ischemia injury. J. Neurochem. 2002;83(5):1172–1179. doi: 10.1046/j.1471-4159.2002.01225.x. [DOI] [PubMed] [Google Scholar]
  • 47.Day P.E.L., et al. Validation of control genes and a standardised protocol for quantifying gene expression in the livers of C57BL/6 and ApoE-/- mice. Sci. Rep. 2018;8(1):8081. doi: 10.1038/s41598-018-26431-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Li C., et al. Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation. Biochemistry (Mosc.) 2012;77(6):671–678. doi: 10.1134/S0006297912060156. [DOI] [PubMed] [Google Scholar]
  • 49.Guan Y.Z., et al. [Involvement of inhibition of nucleus GAPDH over-expression in erythropoietin's reduction of neuronal apoptosis induced by brain ischemia/reperfusion in rats] Sheng Li Xue Bao. 2012;64(3):269–274. [PubMed] [Google Scholar]
  • 50.Zhang Y.L., et al. Blockage of fibronectin 1 ameliorates myocardial ischemia/reperfusion injury in association with activation of AMP-LKB1-AMPK signaling pathway. Oxid. Med. Cell. Longev. 2022;2022 doi: 10.1155/2022/6196173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Li X.L., et al. Effects of Integrin β1 on behavior and neurovascular regeneration in rats with cerebral ischemia-reperfusion injury. Eur. Rev. Med. Pharmacol. Sci. 2019;23(8):3487–3494. doi: 10.26355/eurrev_201904_17714. [DOI] [PubMed] [Google Scholar]
  • 52.Fukuta T., et al. Applications of liposomal drug delivery systems to develop neuroprotective agents for the treatment of ischemic stroke. Biol. Pharm. Bull. 2019;42(3):319–326. doi: 10.1248/bpb.b18-00683. [DOI] [PubMed] [Google Scholar]
  • 53.Cai Y., et al. FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury. Redox Biol. 2021;38 doi: 10.1016/j.redox.2020.101792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Shao Z.Q., et al. Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury. Neural Regen Res. 2021;16(6):1044–1051. doi: 10.4103/1673-5374.300725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gong L., et al. RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis. 2017;8(10):e3080. doi: 10.1038/cddis.2017.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Pinsky M., et al. Human serum Albumin facilitates heme-iron utilization by fungi. mBio. 2020;11(2) doi: 10.1128/mBio.00607-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Belayev L., et al. Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke. 2005;36(2):326–331. doi: 10.1161/01.STR.0000152949.31366.3d. [DOI] [PubMed] [Google Scholar]
  • 58.Peng D.H., et al. Epidermal growth factor alleviates cerebral ischemia-induced brain injury by regulating expression of neutrophil gelatinase-associated lipocalin. Biochem. Biophys. Res. Commun. 2020;524(4):963–969. doi: 10.1016/j.bbrc.2020.02.025. [DOI] [PubMed] [Google Scholar]
  • 59.Tang Y., et al. JAK2/STAT3 pathway is involved in the neffects of epidermal growth factor receptor activation against cerebral ischemia/reperfusion injury in rats. Neurosci. Lett. 2018;662:219–226. doi: 10.1016/j.neulet.2017.10.037. [DOI] [PubMed] [Google Scholar]
  • 60.Ma D., et al. Weighted gene co-expression network analysis to investigate the key genes implicated in global brain ischemia/reperfusion injury in rats. Adv. Clin. Exp. Med. 2020;29(6):649–659. doi: 10.17219/acem/121918. [DOI] [PubMed] [Google Scholar]

Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES